Literature DB >> 25619720

Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis.

Domenico Ribatti1, Beatrice Nico2, Angelo Vacca3.   

Abstract

Bone marrow (BM) contains hematopoietic stem cells (HSCs) and nonhematopoietic cells. HSCs give rise to all types of mature blood cells, while the nonhematopoietic component includes osteoblasts/osteoclasts, endothelial cells (ECs), endothelial progenitor cells (EPCs), and mesenchymal stem cells (MSCs). These cells form specialized "niches" which are close to the vasculature ("vascular niche") or to the endosteum ("osteoblast niche"). The "vascular niche", rich in blood vessels where ECs and mural cells (pericytes and smooth muscle cells), create a microenvironment affecting the behavior of several stem and progenitor cells. The vessel wall acts as an independent niche for the recruitment of EPCs and MSCs. This chapter will focus on the description of the role of BM niches in the control of angiogenesis occurring during multiple myeloma progression.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Multiple myeloma; Osteoblastic niche; Tumor growth; Vascular niche

Mesh:

Year:  2014        PMID: 25619720     DOI: 10.1016/bs.ircmb.2014.10.004

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  15 in total

Review 1.  Nanotherapeutics for multiple myeloma.

Authors:  Alexander Zheleznyak; Monica Shokeen; Samuel Achilefu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-04-26

2.  Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients.

Authors:  Patrizia Leone; Giuseppe Di Lernia; Antonio Giovanni Solimando; Sebastiano Cicco; Ilaria Saltarella; Aurelia Lamanuzzi; Roberto Ria; Maria Antonia Frassanito; Maurilio Ponzoni; Paolo Ditonno; Franco Dammacco; Vito Racanelli; Angelo Vacca
Journal:  Oncoimmunology       Date:  2018-10-22       Impact factor: 8.110

Review 3.  Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.

Authors:  Camille Guillerey; Kyohei Nakamura; Slavica Vuckovic; Geoffrey R Hill; Mark J Smyth
Journal:  Cell Mol Life Sci       Date:  2016-01-22       Impact factor: 9.261

4.  Fibroblast Growth Factor-2 facilitates the growth and chemo-resistance of leukemia cells in the bone marrow by modulating osteoblast functions.

Authors:  Keiki Sugimoto; Yasuhiko Miyata; Takayuki Nakayama; Shigeki Saito; Ritsuro Suzuki; Fumihiko Hayakawa; Satoshi Nishiwaki; Hiroki Mizuno; Kyosuke Takeshita; Hidefumi Kato; Ryuzo Ueda; Akiyoshi Takami; Tomoki Naoe
Journal:  Sci Rep       Date:  2016-08-02       Impact factor: 4.379

5.  NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27.

Authors:  Alessandra Dondero; Beatrice Casu; Francesca Bellora; Angelo Vacca; Annunziata De Luisi; Maria Antonia Frassanito; Claudia Cantoni; Silvia Gaggero; Daniel Olive; Alessandro Moretta; Cristina Bottino; Roberta Castriconi
Journal:  Oncotarget       Date:  2017-05-23

Review 6.  Microenvironment drug resistance in multiple myeloma: emerging new players.

Authors:  Lucia Di Marzo; Vanessa Desantis; Antonio Giovanni Solimando; Simona Ruggieri; Tiziana Annese; Beatrice Nico; Ruggiero Fumarulo; Angelo Vacca; Maria Antonia Frassanito
Journal:  Oncotarget       Date:  2016-09-13

Review 7.  Bone Niches, Hematopoietic Stem Cells, and Vessel Formation.

Authors:  Roberto Tamma; Domenico Ribatti
Journal:  Int J Mol Sci       Date:  2017-01-13       Impact factor: 5.923

Review 8.  High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment.

Authors:  Antonio Giovanni Solimando; Matteo Claudio Da Vià; Sebastiano Cicco; Patrizia Leone; Giuseppe Di Lernia; Donato Giannico; Vanessa Desantis; Maria Antonia Frassanito; Arcangelo Morizio; Julia Delgado Tascon; Assunta Melaccio; Ilaria Saltarella; Giuseppe Ranieri; Roberto Ria; Leo Rasche; K Martin Kortüm; Andreas Beilhack; Vito Racanelli; Angelo Vacca; Hermann Einsele
Journal:  J Clin Med       Date:  2019-07-09       Impact factor: 4.241

Review 9.  New Insights in Anti-Angiogenesis in Multiple Myeloma.

Authors:  Domenico Ribatti; Angelo Vacca
Journal:  Int J Mol Sci       Date:  2018-07-12       Impact factor: 5.923

Review 10.  Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin.

Authors:  Martina Ghetti; Ivan Vannini; Clelia Tiziana Storlazzi; Giovanni Martinelli; Giorgia Simonetti
Journal:  Mol Cancer       Date:  2020-03-30       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.